News >

Langer Highlights the Impact of Chemoimmunotherapy in NSCLC

Angelica Welch
Published: Tuesday, Jul 24, 2018

Corey J. Langer, MD

Corey J. Langer, MD

There has been a major paradigm shift with the combination of immunotherapy and chemotherapy in non–small cell lung cancer (NSCLC), according to Corey J. Langer, MD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Online Medical Crossfire®: 5th Annual Miami Lung Cancer ConferenceMay 30, 20196.5
Community Practice Connections™: Practical Application of Sequencing for EGFR-Mutant Lung Cancers: A Focus on Recent Evidence and Key Next Steps in TrialsJun 29, 20192.5
Publication Bottom Border
Border Publication